N Abrescia

960 total citations
20 papers, 292 citations indexed

About

N Abrescia is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, N Abrescia has authored 20 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 8 papers in Virology and 8 papers in Epidemiology. Recurrent topics in N Abrescia's work include HIV/AIDS Research and Interventions (10 papers), HIV Research and Treatment (8 papers) and HIV/AIDS drug development and treatment (8 papers). N Abrescia is often cited by papers focused on HIV/AIDS Research and Interventions (10 papers), HIV Research and Treatment (8 papers) and HIV/AIDS drug development and treatment (8 papers). N Abrescia collaborates with scholars based in Italy, United Kingdom and United States. N Abrescia's co-authors include Antonella d’Arminio Monforte, Maurizio D’Abbraccio, Adriana Ammassari, Andrea Antinori, Rita Murri, Albert W. Wu, Alessandro Cozzi‐Lepri, Giancarlo Orofino, Cristina Mussini and Salvatore Nappa and has published in prestigious journals such as The Journal of Infectious Diseases, Current Pharmaceutical Design and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

N Abrescia

18 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N Abrescia Italy 7 212 100 75 75 29 20 292
Elías Rodríguez Rodríguez Spain 4 243 1.1× 69 0.7× 108 1.4× 64 0.9× 71 2.4× 11 337
K. Anastos United States 5 259 1.2× 62 0.6× 87 1.2× 166 2.2× 30 1.0× 5 363
Sara Melzi Italy 9 270 1.3× 154 1.5× 59 0.8× 153 2.0× 8 0.3× 10 377
Jamie C. Jordan United States 9 243 1.1× 119 1.2× 68 0.9× 64 0.9× 42 1.4× 9 467
Cathy M. Puskas Canada 8 252 1.2× 72 0.7× 171 2.3× 98 1.3× 56 1.9× 11 306
Susan C. Hunt United States 9 437 2.1× 231 2.3× 204 2.7× 97 1.3× 67 2.3× 16 552
Marcelo Araújo de Freitas Brazil 4 331 1.6× 92 0.9× 153 2.0× 52 0.7× 118 4.1× 7 378
Girish Prajapati United States 10 249 1.2× 95 0.9× 179 2.4× 172 2.3× 31 1.1× 25 436
Ken Ho United States 11 186 0.9× 39 0.4× 126 1.7× 89 1.2× 39 1.3× 42 316
Julia del Amo Spain 9 232 1.1× 69 0.7× 170 2.3× 142 1.9× 18 0.6× 21 327

Countries citing papers authored by N Abrescia

Since Specialization
Citations

This map shows the geographic impact of N Abrescia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Abrescia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Abrescia more than expected).

Fields of papers citing papers by N Abrescia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Abrescia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Abrescia. The network helps show where N Abrescia may publish in the future.

Co-authorship network of co-authors of N Abrescia

This figure shows the co-authorship network connecting the top 25 collaborators of N Abrescia. A scholar is included among the top collaborators of N Abrescia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Abrescia. N Abrescia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abrescia, N, et al.. (2024). Lessons From the Global SARS-CoV-2 Health Emergency for Potential Future Pandemics. Infectious Diseases in Clinical Practice. 32(3). 1 indexed citations
2.
Navarro, Aitor, César Trigueros, R. Jude Samulski, et al.. (2022). Cellular and Structural Characterization of VP1 and VP2 Knockout Mutants of AAV3B Serotype and Implications for AAV Manufacturing. Human Gene Therapy. 33(21-22). 1142–1156. 4 indexed citations
3.
D’Abbraccio, Maurizio, et al.. (2016). Efficacy and Tolerability of Integrase Inhibitors in Antiretroviral-Naive Patients.. PubMed. 17(3). 171–85. 17 indexed citations
4.
Saracino, Annalisa, Patrizia Lorenzini, Sergio Lo Caputo, et al.. (2014). Increased risk of virological failure to the first antiretroviral regimen in HIV‐infected migrants compared to natives: data from the ICONA cohort. Journal of the International AIDS Society. 17(4S3). 19769–19769. 4 indexed citations
5.
Esposito, Vincenzo, Paolo Chiodini, Rosaria Viglietti, et al.. (2011). Safety of fosamprenavir in a cohort of HIV-1-infected patients with co-morbidities.. PubMed. 25(5). 813–9. 2 indexed citations
6.
Trotta, Maria Paola, Adriana Ammassari, Rita Murri, et al.. (2008). Self-Reported Sexual Dysfunction Is Frequent Among HIV-Infected Persons and Is Associated with Suboptimal Adherence to Antiretrovirals. AIDS Patient Care and STDs. 22(4). 291–299. 34 indexed citations
7.
Ammassari, Adriana, Patrizia Lorenzini, Franco Maggiolo, et al.. (2008). Impact of antiretroviral dosing and daily pill burden on viral rebound rates in naive patients receiving a tenofovir-based regimen. Journal of the International AIDS Society. 11(Suppl 1). P3–P3.
8.
Biswas, Priscilla, Alessandro Cozzi‐Lepri, Fanny Delfanti, et al.. (2006). Significant link between sCD30 changes and HIV viremia in patients treated with HAART. Journal of Medical Virology. 78(12). 1513–1519. 9 indexed citations
9.
Abrescia, N, et al.. (2005). Hepatotoxicity of Antiretroviral Drugs. Current Pharmaceutical Design. 11(28). 3697–3710. 35 indexed citations
10.
Abrescia, N, et al.. (2005). Antiretroviral Therapy: Is it the Right Time for New Strategies?. Letters in Drug Design & Discovery. 2(6). 470–474. 1 indexed citations
11.
Cozzi‐Lepri, Alessandro, Andrew Phillips, Antonella d’Arminio Monforte, et al.. (2002). Virologic and Immunologic Response to Regimens Containing Nevirapine or Efavirenz in Combination with 2 Nucleoside Analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) Study. The Journal of Infectious Diseases. 185(8). 1062–1069. 69 indexed citations
12.
Murri, Rita, Andrea Antinori, Adriana Ammassari, et al.. (2002). Physician Estimates of Adherence and the Patient-Physician Relationship as a Setting to Improve Adherence to Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31. S158–S162. 59 indexed citations
13.
Starace, Fabrizio, N Abrescia, Antonio Chirianni, et al.. (2002). Quality of life assessment in HIV-positive persons: Application and validation of the WHOQOL-HIV, Italian version. AIDS Care. 14(3). 405–415. 38 indexed citations
14.
Aloisi, Marta, Diego Serraino, Enrico Girardi, et al.. (2000). Sexual behaviour of women living with HIV/AIDS naïve for antiretroviral therapy: The ICONA-BEHEPI Study. AIDS Care. 12(6). 789–795. 2 indexed citations
15.
Abrescia, N, et al.. (1994). Insulin-Degrading Activity in Experimental LiverCirrhosis of the Rat. PubMed. 48(4). 197–201. 3 indexed citations
16.
Piazza, M, et al.. (1993). [Demonstration of the interchangeability of 2 types of recombinant anti-hepatitis-B vaccine].. PubMed. 69(4). 273–80. 6 indexed citations
17.
Abrescia, N, et al.. (1991). A modified immunisation schedule for the hepatitis B vaccine Recombivax HB suitable for mass vaccination in childhood.. PubMed. 67(2). 207–11. 1 indexed citations
18.
Abrescia, N, et al.. (1987). Prevalence of HBV and HDV markers in families of patients with HBsAg+ chronic liver disease.. PubMed. 234. 381–2. 1 indexed citations
19.
Borgia, Guglielmo, et al.. (1982). Ultrastructural changes in mouse liver cells: A morphometric study on the influence of morphine, heroin, and cardiostenol. Journal of Ultrastructure Research. 80(2). 123–132. 6 indexed citations
20.
Abrescia, N. (1952). [Anatomical and pathological contribution to the study of hemorrhage of the adrenals in newborn infant].. PubMed. 5(6). 645–68.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elías Rodríguez Rodríguez Breakdown of academic impact, for papers by K. Anastos Breakdown of academic impact, for papers by Sara Melzi Breakdown of academic impact, for papers by Jamie C. Jordan Breakdown of academic impact, for papers by Cathy M. Puskas Breakdown of academic impact, for papers by Susan C. Hunt Breakdown of academic impact, for papers by Marcelo Araújo de Freitas Breakdown of academic impact, for papers by Girish Prajapati Breakdown of academic impact, for papers by Ken Ho Breakdown of academic impact, for papers by Julia del Amo
Rankless by CCL
2026